摘要
目的:观察高容量血液滤过(HVHF)防治多脏器功能障碍综合征(MODS)过程中肿瘤坏死因子α(TNF-α)和高迁移率族蛋白1(HMGB1)的变化。方法:19只健康雄性家猪随机分成MODS组(n=9)和HVHF组(n=10),均采用失血性休克复苏+内毒素血症复合因素建立猪MODS模型,HVHF组动物注射内毒素后采用F50聚砜膜滤器予血液滤过,超滤量3 L/h。观察2组动物处死前主要器官功能指标,记录MODS的发生率与病死率。2组均于放血前、内毒素注射前、内毒素注射后1h、24h、48h及96h留取血标本,采用ELISA法测定血浆TNF-α含量,Western blotting法检测血浆HMGB1蛋白含量。结果:2组动物处死前主要器官功能明显改善。HVHF组MODS发生率与病死率均低于MODS组(P<0.05)。MODS组TNF-α和HMGB1均明显升高,HMGB1较TNF-α分泌高峰延迟,持续时间较长;与MODS组相比,HVHF组HMGB1蛋白相对于基础值水平升高幅度明显降低,TNF-α各时间点均有不同程度下降。结论:过度的炎症反应是MODS发生的本质原因之一,HVHF能够削弱血循环中TNF-α和HMGB1等炎症介质的峰值浓度,有效遏制过度的炎症反应,从而起到防治MODS的作用。
Aim: To observe the changes of plasma tumor necrosis factor-alpha (TNF-α) and high mobility group-1 protein(HMGB1 ) in minipigs with multiple organ dysfuncition (MODS) treated with high volume hemofiltration(HVHF). Methods: Nineteen healthy male minipigs were randomly divided into MODS group and HVHF group. Double-hit method was used to establish the porcine MODS model. The animals in HVHF group underwent prophylactic HVHF (3 L/h) after injection of endotoxin. F50 polysulfone membrane filter was used. Plasma levels of TNF-α and HMGB1 at different time points were detected by enzyme-linked immunosorbent assay(ELISA) and Western blotting, respectively, Results: The mobidity of MODS in group HVHF was lower than that in group MODS(P 〈0.05). Main organs' function was improved by HVHF. The plasma levels of TNF-α and HMGB1 obviously elevated in MODS group after the endotoxin injection, and HMGB 1 achieved the peak value later than TNF-α, but it also dropped later; in group HVHF, the increase of HMGB1 com- pared with base level was lower than that in group MODS, and the plasma levels of TNF-α were obviously decreased at vari- ous time points. Conclusion : Excessive inflammatory response may be the essential pathogenesis of MODS. HVHF can cut down the peak value of inflammatory cytokines including TNF-α and HMGB1 protein, which can prevent and treat MODS through restraining excessive inflammatory response.
出处
《郑州大学学报(医学版)》
CAS
北大核心
2008年第3期543-545,共3页
Journal of Zhengzhou University(Medical Sciences)
基金
军队医学研究重点课题01L006